A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

Gout

(2011) Tuhina Neogi   NEW ENGLAND JOURNAL OF MEDICINE

Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study

(2010) Jorge Cortes et al.   JOURNAL OF CLINICAL ONCOLOGY

Uric Acid: A Novel Risk Factor for Acute Kidney Injury in High-Risk Cardiac Surgery Patients?

(2009) A. Ahsan Ejaz et al.   AMERICAN JOURNAL OF NEPHROLOGY

An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome

(2009) Tariq I. Mughal et al.   CANCER TREATMENT REVIEWS

A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome

(2009) M. Shimada et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase

(2008) Margit Hummel et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Tumor lysis syndrome: current perspective

(2008) J. Hochberg et al.   HAEMATOLOGICA

Consensus conference on the management of tumor lysis syndrome

(2008) P. Tosi et al.   HAEMATOLOGICA

Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review

(2008) Bertrand Coiffier et al.   JOURNAL OF CLINICAL ONCOLOGY

Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach

(2008) M. Campara et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS